Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents

Background: Hepatocellular carcinoma (HCC) remains a significant concern for patients with chronic hepatitis C (HCV), even after achieving a sustained virological response (SVR) with direct-acting antivirals (DAAs) or interferon (IFN)-based therapies. This study compared the risk of HCC in patients...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng, Yu-Wen Wen, Yi-Chung Hsieh, Cheng-Er Hsu, Chung-Wei Su, Jennifer Chia-Hung Tai, Yi-Cheng Chen, Wen-Juei Jeng, Chun-Yen Lin, Rong-Nan Chien, Dar-In Tai, I-Shyan Sheen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2024-09-01
Colección:	Viruses
Materias:	hepatocellular carcinoma Hepatitis C virus sustained viral response direct-acting antivirals interferon-based therapy
Acceso en línea:	https://www.mdpi.com/1999-4915/16/9/1485
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!